I. Pretsch

发表

Acute Hemodynamic Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Diastolic Heart Failure (DILATE-1)

S. Rosenkranz, Lothar Roessig, C. Lam, 2014, Chest.

Transcatheter aortic valve implantation in a patient with suspected hereditary von Willebrand disease and severe gastrointestinal bleeding – a case report

R. Greil, U. Hoppe, M. Lichtenauer, 2019, Scottish medical journal.

Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial

C. Binder-Rodriguez, E. Grünig, R. Steringer-Mascherbauer, 2022, European heart journal.

Global research trends in the medical therapy of pulmonary arterial hypertension 2000-2014.

C. Jung, U. Hoppe, M. Lichtenauer, 2016, Pulmonary pharmacology & therapeutics.

[Use of ECMO in adult patients with cardiogenic shock: a position paper of the Austrian Society of Cardiology].

H. Antretter, A. Geppert, D. Zimpfer, 2015, Medizinische Klinik, Intensivmedizin und Notfallmedizin.

Successful long-term antibiotic suppressive therapy in a case of prosthetic valve endocarditis and a case of extensive aortic and subclavian graft infection

C. Dinges, R. Seitelberger, A. Lechner, 2019, Infection.

Soluble suppression of tumorigenicity 2 as outcome predictor after cardiopulmonary resuscitation: an observational prospective study

G. Gemes, M. Lichtenauer, B. Wernly, 2021, Scientific Reports.

Revaskularisation des infarktbedingten kardiogenen Schocks

Einladung Zum Webinar, I. Pretsch, kardiogenen Schocks, 2011 .

Acute hemoDynamic effects of rIociguat in patients with puLmonary hypertension Associated with diasTolic heart failurE (DILATE-1): A randomized, double-blind, placebo-controlled, single-dose study

S. Rosenkranz, Lothar Roessig, J. Parissis, 2013 .

Thinking fast and slow: Lactate and MELD-XI (Model for End-Stage Liver Disease Excluding INR) are useful for estimating mortality after cardiopulmonary resuscitation.

C. Jung, U. Hoppe, B. Strohmer, 2021, Minerva anestesiologica.

Pilot Study of Endothelin Receptor Blockade in Heart Failure with Diastolic Dysfunction and Pulmonary Hypertension (BADDHY-Trial).

H. Ulmer, C. Ebner, J. Schwaiger, 2017, Heart, lung & circulation.

Evaluation of the pharmacoDYNAMIC effects of riociguat in subjects with pulmonary hypertension and heart failure with preserved ejection fraction

S. Ulrich, E. Grünig, J. Mascherbauer, 2016, Wiener klinische Wochenschrift.

Mechanical circulatory support with Impella versus intra-aortic balloon pump or medical treatment in cardiogenic shock—a critical appraisal of current data

H. Thiele, U. Landmesser, C. Jung, 2019, Clinical Research in Cardiology.

Mortality after cardiopulmonary resuscitation on a medical ICU

C. Jung, U. Hoppe, M. Lichtenauer, 2021, Wiener klinische Wochenschrift.